165 related articles for article (PubMed ID: 24400704)
1. Steroid users and the unique challenge they pose to needle and syringe program workers.
Dunn M; McKay FH; Iversen J
Drug Alcohol Rev; 2014 Jan; 33(1):71-7. PubMed ID: 24400704
[TBL] [Abstract][Full Text] [Related]
2. Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.
Van de Ven K; Maher L; Wand H; Memedovic S; Jackson E; Iversen J
Drug Alcohol Rev; 2018 Nov; 37(7):837-846. PubMed ID: 29968372
[TBL] [Abstract][Full Text] [Related]
3. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
4. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
5. Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services?
Dunn M; Henshaw R; McKay FH
Drug Alcohol Rev; 2016 Jul; 35(4):377-82. PubMed ID: 26644363
[TBL] [Abstract][Full Text] [Related]
6. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
7. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
[TBL] [Abstract][Full Text] [Related]
8. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
Rowe R; Berger I; Yaseen B; Copeland J
Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
10. Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
Brener L; Spooner C; Treloar C
Int J Drug Policy; 2010 May; 21(3):160-4. PubMed ID: 19427187
[TBL] [Abstract][Full Text] [Related]
11. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.
Islam M; Stern T; Conigrave KM; Wodak A
Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
13. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
[TBL] [Abstract][Full Text] [Related]
14. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
[TBL] [Abstract][Full Text] [Related]
15. Australia's response to HIV among people who inject drugs.
Madden A; Wodak A
AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
[TBL] [Abstract][Full Text] [Related]
16. The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use.
Hanley Santos G; Coomber R
Int J Drug Policy; 2017 Feb; 40():35-43. PubMed ID: 27955960
[TBL] [Abstract][Full Text] [Related]
17. Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need.
Treloar C; Mao L; Wilson H
Harm Reduct J; 2016 May; 13(1):18. PubMed ID: 27246345
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations.
Treloar C; Newland J; Maher L
Harm Reduct J; 2015 Mar; 12():5. PubMed ID: 25884357
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacist experiences of providing needle and syringe programmes in Ireland.
McVeigh J; Hearne E; Bates G; Van Hout MC
Res Social Adm Pharm; 2017; 13(4):767-777. PubMed ID: 27568822
[TBL] [Abstract][Full Text] [Related]
20. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
